Market by Solution, Technology, Type, Industry Vertical, and Country Outlook | Forecast 2024-2032
Triton’s research report denotes that the artificial intelligence (AI) in healthcare market in North America is predicted to progress in revenue at a CAGR of 36.48% over the forecast period 2024-2032.
Report scope can be customized per your requirements - Request Free Sample Report
The countries reviewed in the region include:
• United
States
• Canada
The robust adoption of Artificial Intelligence
(AI) in North America, notably in the United States, arises from various
factors. The region’s abundance of tech giants and growing startups dedicated
to AI innovation has been pivotal. Additionally, the strategic significance of
AI for the region’s economy and international influence has spurred its
adoption. Furthermore, the prevalent readiness and acceptance of AI among the
populace have facilitated its integration into various sectors.
The United States spearheads the market with the major share. The surge in the United States’ artificial intelligence healthcare market is attributable to several factors, including increased government initiatives and investments in the field. The implementation of regulations and policies aimed at advancing AI in healthcare further propels market growth. Earlier, the United States unveiled a draft outlining plans for a series of workshops and the establishment of a National Science and Technology Council Sub-committee dedicated to AI and machine learning. These initiatives are set to drive progress in AI within the healthcare and medical sectors.
Additionally, the National Institute of Health highlights
the significance of federally-funded research and development in artificial
intelligence for healthcare and robotics, as outlined in the National
Artificial Intelligence Research and Development strategic plan crafted and
enforced by the US government. This further creates numerous opportunities for
the studied market.
Healthcare
providers deliver a range of services to patients and communities through
various institutions like hospitals, diagnostic centers, and pharmacies.
Artificial intelligence (AI) holds promise in revolutionizing healthcare by
offering reliable, high-quality support to healthcare professionals, thus
enhancing safety and efficiency. The
market is categorized into industry vertical, type, technology, and solution.
The industry vertical section includes healthcare providers, payers, patients,
ACOS and MCOS, and pharmaceutical & biotechnology companies.
The leading companies in the market are GE Healthcare, IBM Corporation,
Intel Corporation, General Vision Inc, etc.
GE Healthcare is a global leader in medical technology and digital solutions. Its comprehensive offerings span contrast media, invasive cardiology, computed tomography, interoperability, molecular imaging, bone and metabolic health, anesthesia delivery, patient monitoring, surgical imaging, ultrasound, and more. In addition to its wide range of products and services, the company specializes in interventional image-guided systems, digital solutions, fluoroscopy systems, and clinical network solutions. With its headquarters in Chicago, USA, GE Healthcare operates through subsidiaries and affiliates worldwide.
KEY
DELIVERABLES OF THE REPORT:
●
Market CAGR during the forecasting years 2024-2032
●
Detailed data highlighting key insights, industry components, and
market strategies
●
Comprehensive information and estimation of the artificial intelligence (AI) in healthcare market revenue growth in North America and its influence on
the parent market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape and Porter’s
Five Forces
●
A wide-ranging study of factors that will challenge the North
America artificial
intelligence (AI) in healthcare market’s growth
during the upcoming years
Want to get specific insights? Our team of analysts can customize this
report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PORTER’S
FIVE FORCES ANALYSIS
2.1.1. BUYERS
POWER
2.1.2. SUPPLIERS
POWER
2.1.3. SUBSTITUTION
2.1.4. NEW
ENTRANTS
2.1.5. INDUSTRY
RIVALRY
2.2. MARKET
MATURITY ANALYSIS
2.3. VALUE
CHAIN ANALYSIS
2.3.1. DATA
WAREHOUSE
2.3.2. ARTIFICIAL
INTELLIGENCE (AI) ANALYSIS
2.3.3. SOFTWARE
DEVELOPMENT
2.4. KEY
BUYING CRITERIA
2.4.1. APPLICATION
2.4.2. TECHNOLOGY
2.4.3. INTEGRATION
WITH EXISTING INFRASTRUCTURE
2.5. REGULATORY
FRAMEWORK
2.6. KEY
MARKET STRATEGIES
2.6.1. ACQUISITIONS
2.6.2. PRODUCT
LAUNCHES
2.6.3. COLLABORATIONS
2.7. MARKET
DRIVERS
2.7.1. ADOPTION
OF AI BEING SUPPORTED BY LARGE VOLUMES OF HEALTHCARE DATA
2.7.2. PERSONALIZED
MEDICINE IN TESTS FOR CLINICAL DECISION-MAKING
2.7.3. GROWING
PROACTIVE GOVERNMENT SUPPORT AND INVESTMENTS IN AI R&D
2.7.4. INCREASING
START-UPS IN AI AND MACHINE LEARNING
2.8. MARKET
CHALLENGES
2.8.1. COST
CONSTRAINTS AND A LOW RETURN ON INVESTMENT (ROI)
2.8.2. CHALLENGES
IN SUSTAINING DATA SECURITY
2.8.3. SLOW
ADOPTION OF AI-BASED TECHNOLOGIES
2.9. MARKET
OPPORTUNITIES
2.9.1. EXPANDING
APPLICATIONS OF AI IN THE HEALTHCARE INDUSTRY
2.9.2. RISING
DEMAND FOR AI IN DRUG DISCOVERY
2.9.3. STRONG
FOCUS ON THE DEVELOPMENT OF PRECISION MEDICINE AND PERSONALIZED DRUGS
2.9.4. AI
USED TO ESTABLISH A REAL-TIME MONITORING SYSTEM
2.10. ANALYST
PERSPECTIVE
3. NORTH
AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - BY SOLUTION
3.1. SOFTWARE
3.2. SERVICES
3.3. HARDWARE
4. NORTH
AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - BY TECHNOLOGY
4.1. NATURAL
LANGUAGE PROCESSING
4.2. QUERYING
METHOD
4.3. CONTEXT
AWARE PROCESSING
4.4. DEEP
LEARNING
5. NORTH
AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - BY TYPE
5.1. ROBOT-ASSISTED
SURGERY
5.2. VIRTUAL
NURSING ASSISTANT
5.3. ADMINISTRATIVE
WORKFLOW ASSISTANCE
5.4. FRAUD
DETECTION
5.5. DOSAGE
ERROR REDUCTION
5.6. CLINICAL
TRIAL PARTICIPANT IDENTIFIER
5.7. PRELIMINARY
DIAGNOSIS
5.8. OTHER
APPLICATIONS
6. NORTH
AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - BY INDUSTRY
VERTICAL
6.1. HEALTHCARE
PROVIDERS
6.2. PHARMACEUTICAL
AND BIOTECHNOLOGY COMPANIES
6.3. PAYERS
6.4. ACOS
AND MCOS
6.5. PATIENTS
7. NORTH
AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET – BY COUNTRY OUTLOOK
7.1. UNITED
STATES
7.1.1. UNITED
STATES ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST &
PROSPECTS
7.2. CANADA
7.2.1. CANADA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. GE
HEALTHCARE
8.1.1. OVERVIEW
8.1.2. PRODUCT
LIST
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. GENERAL
VISION INC
8.2.1. OVERVIEW
8.2.2. PRODUCT
LIST
8.3. GOOGLE
LLC
8.3.1. OVERVIEW
8.3.2. PRODUCT
LIST
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. IBM
CORPORATION
8.4.1. OVERVIEW
8.4.2. PRODUCT
LIST
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. INTEL
CORPORATION
8.5.1. OVERVIEW
8.5.2. PRODUCT
LIST
8.5.3. KEY STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. KONINKLIJKE
PHILIPS NV
8.6.1. COMPANY
OVERVIEW
8.6.2. PRODUCTS
8.6.3. KEY
STRENGTHS
8.6.4. KEY
CHALLENGES
8.7. MEDTRONIC
PLC
8.7.1. COMPANY
OVERVIEW
8.7.2. PRODUCT
LIST
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. MICROSOFT
CORPORATION
8.8.1. COMPANY
OVERVIEW
8.8.2. PRODUCT
LIST
8.8.3. KEY
STRENGTHS
8.8.4. KEY CHALLENGES
8.9. NVIDIA
CORPORATION
8.9.1. OVERVIEW
8.9.2. PRODUCT
LIST
8.9.3. KEY
STRENGTHS
8.9.4. KEY
CHALLENGES
8.10. ONCORA
MEDICAL
8.10.1. OVERVIEW
8.10.2. PRODUCT
LIST
8.11. RECURSION
PHARMACEUTICALS INC
8.11.1. OVERVIEW
8.11.2. PRODUCTS
8.12. STRYKER
CORPORATION
8.12.1. OVERVIEW
8.12.2. PRODUCT
LIST
8.12.3. KEY
STRENGTHS
8.12.4. KEY
CHALLENGES
8.13. SIEMENS
HEALTHINEERS AG
8.13.1. OVERVIEW
8.13.2. PRODUCT
LIST
8.13.3. KEY
STRENGTHS
8.13.4. KEY
CHALLENGES
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY COUNTRY OUTLOOK,
HISTORICAL YEARS, 2020-2023 (IN $ MILLION)
TABLE 2: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY COUNTRY OUTLOOK, FORECAST
YEARS, 2024-2032 (IN $ MILLION)
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: LIST OF
COLLABORATIONS
TABLE 6: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY SOLUTION, 2024-2032 (IN $
MILLION)
TABLE 7: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024-2032 (IN
$ MILLION)
TABLE 8: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TYPE, 2024-2032 (IN $
MILLION)
TABLE 9: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY INDUSTRY VERTICAL,
2024-2032 (IN $ MILLION)
TABLE 10: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY COUNTRY OUTLOOK,
2024-2032 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: MARKET MATURITY
ANALYSIS
FIGURE 3: VALUE CHAIN ANALYSIS
FIGURE 4: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY SOLUTION, 2023 & 2032
(IN %)
FIGURE 5: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY SOFTWARE, 2024-2032 (IN $
MILLION)
FIGURE 6: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY SERVICES, 2024-2032 (IN $
MILLION)
FIGURE 7: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY HARDWARE, 2024-2032 (IN $
MILLION)
FIGURE 8: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023 &
2032 (IN %)
FIGURE 9: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY NATURAL LANGUAGE
PROCESSING, 2024-2032 (IN $ MILLION)
FIGURE 10: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY QUERYING METHOD,
2024-2032 (IN $ MILLION)
FIGURE 11: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY CONTEXT AWARE PROCESSING,
2024-2032 (IN $ MILLION)
FIGURE 12: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY DEEP LEARNING, 2024-2032
(IN $ MILLION)
FIGURE 13: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TYPE, 2023 & 2032 (IN
%)
FIGURE 14: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY ROBOT-ASSISTED SURGERY,
2024-2032 (IN $ MILLION)
FIGURE 15: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY VIRTUAL NURSING
ASSISTANT, 2024-2032 (IN $ MILLION)
FIGURE 16: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY ADMINISTRATIVE WORKFLOW
ASSISTANCE, 2024-2032 (IN $ MILLION)
FIGURE 17: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY FRAUD DETECTION,
2024-2032 (IN $ MILLION)
FIGURE 18: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY DOSAGE ERROR REDUCTION,
2024-2032 (IN $ MILLION)
FIGURE 19: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY CLINICAL TRIAL
PARTICIPANT IDENTIFIER, 2024-2032 (IN $ MILLION)
FIGURE 20: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY PRELIMINARY DIAGNOSIS,
2024-2032 (IN $ MILLION)
FIGURE 21: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY OTHER TYPES, 2024-2032
(IN $ MILLION)
FIGURE 22: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY INDUSTRY VERTICAL, 2023
& 2032 (IN %)
FIGURE 23: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY HEALTHCARE PROVIDERS,
2024-2032 (IN $ MILLION)
FIGURE 24: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY PHARMACEUTICAL AND
BIOTECHNOLOGY COMPANIES, 2024-2032 (IN $ MILLION)
FIGURE 25: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY PAYERS, 2024-2032 (IN $
MILLION)
FIGURE 26: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY ACOS AND MCOS, 2024-2032
(IN $ MILLION)
FIGURE 27: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY PATIENTS, 2024-2032 (IN $
MILLION)
FIGURE 28: NORTH AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY COUNTRY OUTLOOK, 2023
& 2032 (IN %)
FIGURE 29: UNITED STATES
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)
FIGURE 30: CANADA ARTIFICIAL
INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $ MILLION)